東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Development and application of modif...

Hill, Tanner Kinkade.

Linked to FindBook

Google Book

Amazon

博客來

Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery./
Author:	Hill, Tanner Kinkade.
Description:	204 p.
Notes:	Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.
Contained By:	Dissertation Abstracts International76-11B(E).
Subject:	Pharmaceutical sciences. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3712422
ISBN:	9781321892406

Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery.
Hill, Tanner Kinkade.

Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery. - 204 p.

Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.

Thesis (Ph.D.)--Wake Forest University, 2015.

This item is not available from ProQuest Dissertations & Theses.

This work presents research using the natural carbohydrate glycosaminoglycan hyaluronic acid (HLA) as a hydrophilic polymer backbone for the synthesis of nanoscale polymeric micelles loaded with either the near infrared (NIR) fluorophore indocyanine green (ICG) for image guided surgery (IGS), or the fatty acid synthase (FASN) inhibitor Orlistat (ORL) for chemotherapy. Hydrophobic conjugates were synthesized and conjugated to HLA in order to drive self-assembly into nanoparticles (NPs) and load their respective payloads. Chemical composition was confirmed by mass spectrometry and NMR. NP self-assembly was confirmed by dynamic light scattering (DLS) and atomic force microscopy. Optical properties of ICG-loaded NPs, termed NanoICG, were examined and ICG loading was found to be dependent on the structure of the hydrophobic ligand. Fluorescence quenching was observed in aqueous solution, and fluorescence could be reactivated by dissolution in a H2O:DMSO mixture, or in PBS with bovine serum albumin (BSA). ICG release to BSA was observed in vitro. Nano-ICG was found to have negligible cytotoxicity at physiologically relevant concentrations. In vivo results in a xenograft mouse model demonstrated that NanoICG provided superior contrast between tumor and surrounding muscle tissue, and NanoICG successfully identified positive margins (PMs). ORL was successfully loaded into NPs, termed Nano-ORL, at a loading efficiency of approximately 98%. Hydrodynamic diameter was found to be dependent on ORL content. ORL extracted from Nano-ORL successfully inhibited FASN similarly to free ORL, and Nano-ORL inhibited lipid synthesis in cells at approximately the same level as free ORL. Nano-ORL was found to be more cytotoxic than free ORL, and it was found that pre-incubation of both Nano-ORL and free ORL for 24 hours resulted in significantly reduced cytotoxicity of free ORL, while Nano-ORL remained just as cytotoxic. Metabolic analysis showed that Nano-ORL has a similar, negative impact on cellular metabolism as free ORL. These results present novel contributions in the form of the comparison of hydrophobic ligand structure in the loading of ICG into NPs, and the improved tumor accumulation and contrast achieved in vivo. Additionally, these results present the first HLA-derived NP formulation of ORL for use as a FASN inhibitor chemotherapeutic, and show that Nano-ORL has equal or greater activity against cancer cell lines than free ORL.

ISBN: 9781321892406Subjects--Topical Terms:

3173021
Pharmaceutical sciences.

Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery.
LDR:03475nmm a2200301 4500 001 2075931
005 20161028152027.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321892406
035 $a (MiAaPQ)AAI3712422
035 $a AAI3712422
040 $a MiAaPQ $c MiAaPQ
100 1 $a Hill, Tanner Kinkade. $3 3191353
245 1 0 $a Development and application of modified hylauronic acid derived nanoparticles for image guided surgery and drug delivery.
300 $a 204 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-11(E), Section: B.
500 $a Adviser: Aaron M. Mohs.
502 $a Thesis (Ph.D.)--Wake Forest University, 2015.
506 $a This item is not available from ProQuest Dissertations & Theses.
520 $a This work presents research using the natural carbohydrate glycosaminoglycan hyaluronic acid (HLA) as a hydrophilic polymer backbone for the synthesis of nanoscale polymeric micelles loaded with either the near infrared (NIR) fluorophore indocyanine green (ICG) for image guided surgery (IGS), or the fatty acid synthase (FASN) inhibitor Orlistat (ORL) for chemotherapy. Hydrophobic conjugates were synthesized and conjugated to HLA in order to drive self-assembly into nanoparticles (NPs) and load their respective payloads. Chemical composition was confirmed by mass spectrometry and NMR. NP self-assembly was confirmed by dynamic light scattering (DLS) and atomic force microscopy. Optical properties of ICG-loaded NPs, termed NanoICG, were examined and ICG loading was found to be dependent on the structure of the hydrophobic ligand. Fluorescence quenching was observed in aqueous solution, and fluorescence could be reactivated by dissolution in a H2O:DMSO mixture, or in PBS with bovine serum albumin (BSA). ICG release to BSA was observed in vitro. Nano-ICG was found to have negligible cytotoxicity at physiologically relevant concentrations. In vivo results in a xenograft mouse model demonstrated that NanoICG provided superior contrast between tumor and surrounding muscle tissue, and NanoICG successfully identified positive margins (PMs). ORL was successfully loaded into NPs, termed Nano-ORL, at a loading efficiency of approximately 98%. Hydrodynamic diameter was found to be dependent on ORL content. ORL extracted from Nano-ORL successfully inhibited FASN similarly to free ORL, and Nano-ORL inhibited lipid synthesis in cells at approximately the same level as free ORL. Nano-ORL was found to be more cytotoxic than free ORL, and it was found that pre-incubation of both Nano-ORL and free ORL for 24 hours resulted in significantly reduced cytotoxicity of free ORL, while Nano-ORL remained just as cytotoxic. Metabolic analysis showed that Nano-ORL has a similar, negative impact on cellular metabolism as free ORL. These results present novel contributions in the form of the comparison of hydrophobic ligand structure in the loading of ICG into NPs, and the improved tumor accumulation and contrast achieved in vivo. Additionally, these results present the first HLA-derived NP formulation of ORL for use as a FASN inhibitor chemotherapeutic, and show that Nano-ORL has equal or greater activity against cancer cell lines than free ORL.
590 $a School code: 0248.
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Nanotechnology. $3 526235
650 4 $a Medical imaging. $3 3172799
690 $a 0572
690 $a 0652
690 $a 0574
710 2 $a Wake Forest University. $b Biomedical Engineering. $3 3191354
773 0 $t Dissertation Abstracts International $g 76-11B(E).
790 $a 0248
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3712422